Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3

Three series of compounds were designed, synthesized and evaluated for their anticancer activity against a procaspase-3 over-expression cancer cell line (U937) and a procaspase-3 no-expression cancer cell line (MCF-7) to rule out off-target effects. Biological evaluation led to the identification of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MedChemComm 2019-03, Vol.10 (3), p.465-477
Hauptverfasser: Ma, Junjie, Ni, Xin, Gao, Yali, Huang, Kun, Liu, Jiaan, Wang, Yu, Chen, Roufen, Wang, Cuifang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Three series of compounds were designed, synthesized and evaluated for their anticancer activity against a procaspase-3 over-expression cancer cell line (U937) and a procaspase-3 no-expression cancer cell line (MCF-7) to rule out off-target effects. Biological evaluation led to the identification of a series of benzothiazole derivatives bearing a pyridine-semicarbazone moiety, and , with promising anticancer activity and remarkable selectivity. Further mechanism studies revealed that compounds and could induce apoptosis of cancer cells by activating procaspase-3 to caspase-3, and compound exhibited the strongest procaspase-3 activation activity. Structure-activity relationships (SARs) revealed that the presence of benzothiazole and an , , -donor set is crucial for the anticancer activity and selectivity, and reducing the electron density of the , , -donor set results in a dramatic decline in the anticancer activity and selectivity. Furthermore, toxicity evaluation (zebrafish) and metabolic stability studies (human, rat and mouse liver microsomes) were performed to provide reliable guidance for further PK/PD studies .
ISSN:2040-2503
2040-2511
DOI:10.1039/c8md00624e